About

Dupixent is used to treat 6 different conditions with inflammation as a symptom. Dupixent reduces inflammation, relieving symptoms of eczema, asthma, chronic rhinosinusitis, COPD, eosinophilic esophagitis, and prurigo nodularis. FDA approval is granted under the following criteria.

Eczema.Dupixent is used for eczema (atopic dermatitis) that is moderate to severe in adults and children 6 months and older whose condition is not well controlled with prescription treatments used on the skin (topical) or who cannot use topical therapies. Dupixent for eczema can be used with or without topical corticosteroids.

Asthma.In adults and children aged 6 and older Dupixent treats moderate-to-severe eosinophilic or oral-corticosteroid-dependent asthma in addition to other asthma maintenance treatments. Dupixent will NOT treat an acute asthma attack or status asthmatics (an extreme form of acute asthma).

Chronic rhinosinusitis with nasal polyps.Dupixent is used for inadequately controlled chronic rhinosinusitis (a long-standing inflammation of the sinuses) with nasal polyps, as an add-on maintenance treatment in adults and children aged 12 years and older.

COPD.In adults, Dupixent can be used forinadequately controlled COPDwith an eosinophilic phenotype as an add-on maintenance treatment.

EOE.Dupixent is also used foreosino